Mayo v. Prometheus -- Implications for Diagnostics, Biomarkers, and Personalized Medicine


In This Presentation:

- What *Should* be Eligible for a Patent?

- And According to Congress

- What are the Exceptions to Eligibility?

- Mayo Collaborative Services v. Prometheus Laboratories, 566 U.S. __ (March 20, 2012)

- Sample Claim in Prometheus

- The “Law of Nature”

- The Decision

- The “Administering” Step

- The “Determining” Step

- The “Wherein” Clauses

- Myriad on Remand after Prometheus– What to Expect?

- Myriad “Isolated DNA”Claims

- Myriad Diagnostics Claims

- Myriad Screening Claims

- Where Does the Case Law Leave Us?

- Enforcing Patents and “Split Infringement”

- Akamai v. Limelight (continued)

- McKesson v. Epic Systems (Fed. Cir. 2011)

- Akamai and McKesson

- Akamai and McKesson – What Impact?

- Recommendations after Prometheus

- Hint #1: Include Significant “Post-Solution Activity”

- Hint #2: Include “Several Unconventional Steps”

- Hint #3: Avoid “improperly tying up the future use of laws of nature”

- Hint #4

Please see full presentation below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Sterne, Kessler, Goldstein & Fox P.L.L.C. | Attorney Advertising

Written by:


Sterne, Kessler, Goldstein & Fox P.L.L.C. on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.